(IN BRIEF) Almirall has signed a collaboration and licensing agreement with Shanghai Huaota Biopharmaceutical, a subsidiary of Zhejiang Huahai Pharmaceutical, to develop a monoclonal antibody candidate for multiple indications including medical dermatology, with Huaota leading early research and initial clinical … Read the full press release →
Posted in Business, Healthcare, Management, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, Almirall and Huaota Enter Global Licensing Agreement to Develop Monoclonal Antibody for Multiple Indications, Barcelona, biologics, biopharmaceutical, CHINA, clinical development, Cutia, INNOVATION, Karl Ziegelbauer, licensing agreement, medical dermatology, monoclonal antibody, pharmaceutical partnerships, R and D, Shanghai Huaota Biopharmaceutical, Simcere, Sinomune, Zhejiang Huahai Pharmaceutical
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
